Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Proxima MammoSite RTS For Early-Stage Breast Cancer To Launch By May 17

This article was originally published in The Gray Sheet

Executive Summary

Proxima Therapeutics will emphasize its single-catheter MammoSite radiation therapy system's ease of use over multi-catheter competitor devices in treating early-stage breast cancer
Advertisement

Related Content

Cautious Report Unlikely To Slow Partial-Breast Irradiation Market, Firms Say
Cautious Report Unlikely To Slow Partial-Breast Irradiation Market, Firms Say
Cytyc Pays 10-Times Sales For Proxima, Breast Cancer Therapy Market Entry
Cytyc Pays 10-Times Sales For Proxima, Breast Cancer Therapy Market Entry
Nucletron Kuske Template Reduces Breast Brachytherapy Treatment Time
Nucletron Kuske Template Reduces Breast Brachytherapy Treatment Time
Advertisement
UsernamePublicRestriction

Register

MT016554

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel